Hansi Dean

2.4k total citations
46 papers, 942 citations indexed

About

Hansi Dean is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Hansi Dean has authored 46 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 22 papers in Public Health, Environmental and Occupational Health and 16 papers in Epidemiology. Recurrent topics in Hansi Dean's work include Mosquito-borne diseases and control (22 papers), Viral Infections and Vectors (17 papers) and Herpesvirus Infections and Treatments (11 papers). Hansi Dean is often cited by papers focused on Mosquito-borne diseases and control (22 papers), Viral Infections and Vectors (17 papers) and Herpesvirus Infections and Treatments (11 papers). Hansi Dean collaborates with scholars based in United States, Japan and Singapore. Hansi Dean's co-authors include Andrew Cheung, Joel R. Haynes, Deborah H. Fuller, Dexiang Chen, Scott S. Terhune, Patricia G. Spear, Michael D. Macklin, Suzanne Jones, Robert J. Drape and Jorge E. Osorio and has published in prestigious journals such as Nature Communications, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Hansi Dean

43 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hansi Dean United States 18 380 317 256 202 179 46 942
Nicolas Collin Switzerland 21 438 1.2× 321 1.0× 433 1.7× 519 2.6× 240 1.3× 49 1.3k
J. Aucouturier France 10 178 0.5× 181 0.6× 399 1.6× 81 0.4× 241 1.3× 11 815
Nani Wibowo Australia 11 246 0.6× 351 1.1× 451 1.8× 55 0.3× 492 2.7× 20 1.3k
Frederick R. Vogel United States 20 569 1.5× 289 0.9× 687 2.7× 87 0.4× 422 2.4× 29 1.4k
Jose M. Galarza United States 12 519 1.4× 408 1.3× 193 0.8× 160 0.8× 296 1.7× 18 971
Helena Lage Ferreira Brazil 19 658 1.7× 397 1.3× 138 0.5× 186 0.9× 136 0.8× 86 1.1k
Jayesh Meanger Australia 21 601 1.6× 882 2.8× 351 1.4× 88 0.4× 272 1.5× 32 1.6k
J. C. S. Clegg United Kingdom 26 487 1.3× 1.0k 3.2× 243 0.9× 406 2.0× 515 2.9× 41 1.8k
Chinglai Yang United States 25 945 2.5× 804 2.5× 470 1.8× 106 0.5× 438 2.4× 46 2.1k
Ángela M. Arenas-Gamboa United States 20 601 1.6× 94 0.3× 312 1.2× 131 0.6× 202 1.1× 51 1.6k

Countries citing papers authored by Hansi Dean

Since Specialization
Citations

This map shows the geographic impact of Hansi Dean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hansi Dean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hansi Dean more than expected).

Fields of papers citing papers by Hansi Dean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hansi Dean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hansi Dean. The network helps show where Hansi Dean may publish in the future.

Co-authorship network of co-authors of Hansi Dean

This figure shows the co-authorship network connecting the top 25 collaborators of Hansi Dean. A scholar is included among the top collaborators of Hansi Dean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hansi Dean. Hansi Dean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bell, Callum J., Nicholas P. Devitt, Faye Schilkey, et al.. (2024). Identification and quantitation of multiple variants in RNA virus genomes. Biology Methods and Protocols. 9(1). bpae004–bpae004.
2.
3.
Tsuji, Isamu, Fue Vang, Jill A. Livengood, et al.. (2022). Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function. Journal of Virology. 96(11). e0007122–e0007122. 5 indexed citations
4.
DeMaso, Christina R., et al.. (2022). Specificity and Breadth of the Neutralizing Antibody Response to a Live-Attenuated Tetravalent Dengue Vaccine. The Journal of Infectious Diseases. 226(11). 1959–1963. 8 indexed citations
5.
Raju, Nagarajan, Xiaoyan Zhan, Subash C. Das, et al.. (2022). Neutralization fingerprinting technology for characterizing polyclonal antibody responses to dengue vaccines. Cell Reports. 41(11). 111807–111807. 1 indexed citations
6.
Kim, Eun‐Young, Yan Che, Hansi Dean, et al.. (2022). Transcriptome-wide changes in gene expression, splicing, and lncRNAs in response to a live attenuated dengue virus vaccine. Cell Reports. 38(6). 110341–110341. 9 indexed citations
7.
Tsuji, Isamu, et al.. (2021). Development of a Novel Assay to Assess the Avidity of Dengue Virus-Specific Antibodies Elicited in Response to a Tetravalent Dengue Vaccine. The Journal of Infectious Diseases. 225(9). 1533–1544. 10 indexed citations
8.
Giebler, Holli A., Janae L. Stovall, Ginger Young, et al.. (2021). Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus. Nature Communications. 12(1). 7320–7320. 3 indexed citations
9.
Tambyah, Paul Anantharajah, Jolene Oon, Shi-Hsia Hwa, et al.. (2019). An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages. Vaccine. 37(31). 4344–4353. 14 indexed citations
10.
Wee, Edmund G., Torben Schiffner, Celia C. LaBranche, et al.. (2017). HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers. PLoS ONE. 12(8). e0181886–e0181886. 12 indexed citations
11.
Safrit, Jeffrey T., et al.. (2016). Status of vaccine research and development of vaccines for HIV-1. Vaccine. 34(26). 2921–2925. 22 indexed citations
12.
Clutton, Genevieve, et al.. (2014). Optimizing parallel induction of HIV type 1-specific antibody and T-cell responses by multicomponent subunit vaccines. AIDS. 28(17). 2495–2504. 9 indexed citations
13.
Champiat, Stéphane, Rui André Saraiva Raposo, Nicholas J. Maness, et al.. (2012). Influence of HAART on Alternative Reading Frame Immune Responses over the Course of HIV-1 Infection. PLoS ONE. 7(6). e39311–e39311. 17 indexed citations
14.
Dean, Hansi & Dexiang Chen. (2004). Epidermal powder immunization against influenza. Vaccine. 23(5). 681–686. 48 indexed citations
15.
Chen, Dexiang, Melissa Burger, Qili Chu, et al.. (2004). Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity. Virus Research. 103(1-2). 147–153. 17 indexed citations
16.
Dean, Hansi, et al.. (2003). Prevention of persistent infection in calves by vaccination of dams with noncytopathic type-1 modified-live bovine viral diarrhea virus prior to breeding. American Journal of Veterinary Research. 64(5). 530–537. 31 indexed citations
17.
Dean, Hansi, et al.. (1999). Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge. Vaccine. 17(9-10). 1117–1124. 50 indexed citations
18.
Dean, Hansi, Janice Μ. Miller, Mark R. Ackermann, et al.. (1996). Replication and Pathogenicity after Intranasal and Intracranial Inoculation of Swine with a Recombinant Pseudorabies Virus Containing a Deletion at the UL/IR Junction. Virology. 223(1). 19–28. 3 indexed citations
19.
Moriuchi, Masako, et al.. (1995). Pseudorabies Virus EP0 Is Functionally Homologous to Varicella-Zoster Virus ORF61 Protein and Herpes Simplex Virus Type 1 ICP0. Virology. 209(1). 281–283. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas Collin Breakdown of academic impact, for papers by J. Aucouturier Breakdown of academic impact, for papers by Nani Wibowo Breakdown of academic impact, for papers by Frederick R. Vogel Breakdown of academic impact, for papers by Jose M. Galarza Breakdown of academic impact, for papers by Helena Lage Ferreira Breakdown of academic impact, for papers by Jayesh Meanger Breakdown of academic impact, for papers by J. C. S. Clegg Breakdown of academic impact, for papers by Chinglai Yang Breakdown of academic impact, for papers by Ángela M. Arenas-Gamboa
Rankless by CCL
2026